Cell-Based Toxin Detection Using Reporter Gene Luminescence

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting staphylococcal enterotoxins are inefficient, require expensive instrumentation, and cannot distinguish between active and inactive toxins, posing challenges for rapid and accurate detection in food safety and security contexts.

Innovation Solution

A cell-based assay system utilizing a reporter gene expression system that produces a luminescent signal upon exposure to microbial toxins, allowing for sensitive detection and differentiation between active and inactive toxins using chemiluminescence imaging technology.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If animal model tests are used for toxin detection, then detection capability is achieved, but sensitivity is insufficient and ethical concerns arise

Engineering Contradiction:
Improvedetection sensitivityVSAvoidethical concerns and animal welfare
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent creates a cell-based assay system that copies the biological response mechanisms of whole animals at the cellular level. Engineered cell lines with reporter genes replicate the immune system's response to superantigens, providing ethically acceptable alternatives that maintain detection sensitivity while eliminating animal welfare concerns.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent replaces the complex mechanical and physiological systems of whole animal models with simplified in vitro cell-based systems. By substituting animal organisms with engineered cell lines that produce measurable luminescent signals, the system achieves comparable detection capability without the complexities and ethical issues of whole animal testing.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If conventional detection methods are used, then detection is possible, but the cost of instrumentation is high

Engineering Contradiction:
Improvedetection capabilityVSAvoidinstrumentation cost
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent employs disposable cell-based assay plates and reagents that can be easily manufactured and distributed. The cell lines are engineered to provide stable, measurable responses without requiring expensive, complex instrumentation, making the system accessible to laboratories with limited resources while maintaining high detection precision.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Loss of information

If standard assays are used, then toxin presence is detected, but active vs inactive toxin differentiation is not achieved

Engineering Contradiction:
Improvetoxin activity status informationVSAvoiddetection accuracy
Core Design Contradiction:
Loss of informationVSMeasurement precision

Solution Approach 1:

The patent introduces functional differentiation at the cellular level by engineering specific cell lines that respond only to active toxins. The reporter gene expression is triggered by specific biological interactions that occur only with biologically active superantigens, allowing local differentiation of toxin activity status within the assay system and providing accurate information about toxin functionality.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enables rapid, economical, and highly sensitive detection of microbial toxins, achieving detection limits one billion times more sensitive than animal models and one million times more sensitive than ELISA-based assays, effectively discerning active from inactive toxins.

Implementation Method 1

utilize a cell-based assay system that utilizes a reporter gene expression system which produces a luminescent signal upon exposure to microbial toxins

Methodology Applied
Scientific EffectChemiluminescence: Chemiluminescence

Data Source

PatentUS10577667B2Systems and methods for microbial toxin detection
Publication Date: 2020.03.03 THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
  • US10577667B2 patent drawing
  • US10577667B2 patent drawing
  • US10577667B2 patent drawing

AI summary

Systems and methods for detecting microbial toxins are disclosed. The system includes an imaging device operable to detect a luminescent signal and an analysis plate having a well to hold a sample containing the microbial toxin. The luminescence is created by a cell line expressing a product capable of reacting directly or indirectly with the microbial toxin to produce the luminescent signal. The signal is processed via an image processing system operable to receive the luminescent signal detected by the imaging device and convert the luminescent signal to a quantitative measurement correlated to an amount of the microbial toxin present in the sample.